| 摘要 |
The invention concerns the use of at least an aminothiolester derivative for preparing a pharmaceutical composition for lifting the inhibition of a characteristic resistant to apoptosis induction in transformed cells, said characteristic arising from the presence of bcl2 gene in said cells. The pharmaceutical composition is more particularly for treating pathologies including breast cancer, B cell lymphoma, leukaemia, neuroblastoma, prostate adenocarcinoma, prolactinoma and other pituitary adenomas.
|
